VivoSim Labs faces Nasdaq delisting risk after falling below $2.5 million stockholders’ equity requirement
VIVS•Compliance plan and current status
A plan to regain compliance is due by Sept. 3, 2026; Nasdaq can grant time until Jan. 16, 2027.
The Nasdaq notice does not immediately affect trading; shares remain listed on the Nasdaq Capital Market under VIVS.
Stockholders’ equity now exceeds $2.5 million following a $5 million milestone payment and about $4 million private placement proceeds.
Nasdaq notice for equity deficiency
VivoSim Labs received a Nasdaq notice on July 20, 2026 for failing the $2.5 million minimum stockholders’ equity rule.
Equity was $(1.1) million in the annual report for the period ended March 31, 2026, triggering non-compliance.
